Edico Genome
San Diego
About Edico Genome
Edico Genome develops bioinformatics processor chips for DNA analysis designed to analyze sequencing data. The company's DRAGEN platform uses a field-programmable gate array to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and haplotype variant calling, enabling healthcare institutions to easily discover links between DNA sequence variations and human disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $32.0M
- Funding stage: M&A
- Last round: Series B (May 2017)
- Website: edicogenome.com
- Phone: +1 858 699 1212
Industries & Categories
Big Data, Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/edico-genome-6022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.